P2X7 mRNA expression in non‑small cell lung cancer: MicroRNA regulation and prognostic value

Boldrini,Laura; Giordano,Mirella; Alì,Greta; Melfi,Franca; Romano,Gaetano; Lucchi,Marco; Fontanini,Gabriella

doi:10.3892/ol.2014.2620

P2X7 mRNA expression in non‑small cell lung cancer: MicroRNA regulation and prognostic value

Authors:
- Laura Boldrini
- Mirella Giordano
- Greta Alì
- Franca Melfi
- Gaetano Romano
- Marco Lucchi
- Gabriella Fontanini
View Affiliations

Affiliations: Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa 56126, Italy, Unit of Pathological Anatomy III, University Hospital of Pisa, Pisa 56126, Italy, Unit of Thoracic Surgery, University Hospital of Pisa, Pisa 56126, Italy
Published online on: October 15, 2014 https://doi.org/10.3892/ol.2014.2620
Pages: 449-453

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The human P2X7 receptor is significant and exhibits several functions in neoplasia. At present, little is known with regard to its regulation. P2X7 expression may be regulated post‑transcriptionally and putative microRNA (miRNA) binding sites are considered to be involved. The aim of this study was to determine whether miRNAs (miR‑21, let‑7 g and miR‑205) regulate P2X7 mRNA stability. In addition, the impact of P2X7 expression in patients with non‑small cell lung cancer (NSCLC) was investigated. P2X7 mRNA and mature Let‑7 g, miR‑21, and miR‑205 expression levels were quantified in 96 NSCLC cases using quantitative reverse transcription polymerase chain reaction. In all samples, epidermal growth factor receptor and K‑Ras mutational analysis was also performed. Samples with low P2X7 expression were found to exhibit a higher fold change in miR‑21 expression when compared with samples exhibiting high P2X7 expression. Significantly higher miR‑21 expression was observed in the tumors of NSCLC patients with a K‑Ras mutation when compared with patients who had K‑Ras wild‑type tumors (P=0.003). Additionally, to evaluate the association between P2X7 expression and prognosis in NSCLC patients, survival analysis was performed using the Kaplan‑Meier method. A significant difference in the progression‑free survival and overall survival in the NSCLC patients with high P2X7 expression was identified, when compared with that of patients with low expression (P=0.03 and P=0.02, respetively). Therefore, we hypothesized that high levels of miR‑21 expression in NSCLC patients with K‑Ras mutations may be regulated by a complex circuit, including P2X7 downregulation and together these processes may promote tumor progression.

View Figures

View References

1	Buell GN, Talabot F, Gos A, Lorenz J, Lai E, Morris MA and Antonarakis SE: Gene structure and chromosomal localization of the human P2X7 receptor. Receptors Channels. 5:347–354. 1998.PubMed/NCBI
2	Sluyter R and Stokes L: Significance of P2X7 receptor variants to human health and disease. Recent Pat DNA Gene Seq. 5:41–54. 2011. View Article : Google Scholar : PubMed/NCBI
3	Li X, Qi X, Zhou L, Catera D, Rote NS, Potashkin J, Abdul-Karim FW and Gorodeski GI: Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells. Gynecol Oncol. 106:233–243. 2007. View Article : Google Scholar : PubMed/NCBI
4	Zhou L, Qi X, Potashkin JA, Abdul-Karim FW and Gorodeski GI: MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3′-untranslated region of the gene that decrease steadystate levels of the transcript. J Biol Chem. 283:28274–28286. 2008. View Article : Google Scholar : PubMed/NCBI
5	Rahman OA, Sasvari-Szekely M, Szekely A, Faludi G, Guttman A and Nemoda Z: Analysis of a polymorphic microRNA target site in the purinergic receptor P2RX7 gene. Electrophoresis. 31:1790–1795. 2010. View Article : Google Scholar : PubMed/NCBI
6	Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
7	Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R and Pasquinelli AE: Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell. 122:553–563. 2005. View Article : Google Scholar : PubMed/NCBI
8	Lim LP, Lau NC, Garrett-Engele P, et al: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
9	Lai EC: Predicting and validating microRNA targets. Genome Biol. 5:1152004. View Article : Google Scholar : PubMed/NCBI
10	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
11	Xie X, Lu J, Kulbokas EJ, et al: Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature. 434:338–345. 2005. View Article : Google Scholar : PubMed/NCBI
12	Travis WD, Brambilla E, Muller-Hemerlink HK and Harris CC: World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart Lyon, France: IARC Press; 2004
13	Travis WD, Brambilla E, Noguchi M, et al: International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 6:244–285. 2011. View Article : Google Scholar : PubMed/NCBI
14	Capodanno A, Boldrini L, Alì G, Pelliccioni S, Mussi A and Fontanini G: Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumors. Oncol Rep. 28:1559–1566. 2012.PubMed/NCBI
15	Fuller SJ, Stokes L, SkarRatt KK, Gu BJ and Wiley JS: Genetics of the P2X7 receptor and human disease. Purinergic Signal. 5:257–262. 2009. View Article : Google Scholar : PubMed/NCBI
16	Brennecke J, Stark A, Russell RB and Cohen SM: Principles of microRNA-target recognition. PLoS Biol. 3:e852005. View Article : Google Scholar : PubMed/NCBI
17	Mulrane L, McGee SF, Gallagher WM and O’Connor DP: miRNA dysregulation in breast cancer. Cancer Res. 73:6554–6562. 2013. View Article : Google Scholar : PubMed/NCBI
18	Capodanno A, Boldrini L, Proietti A, et al: Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features. Int J Oncol. 43:765–774. 2013.PubMed/NCBI
19	Adinolfi E, Raffaghello L, Giuliani AL, et al: Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res. 72:2957–2969. 2012. View Article : Google Scholar : PubMed/NCBI
20	White N and Burnstock G: P2 receptors and cancer. Trends Pharmacol Sci. 27:211–217. 2006. View Article : Google Scholar : PubMed/NCBI
21	Adinolfi E, Melchiorri L, Falzoni S, et al: P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood. 99:706–708. 2002. View Article : Google Scholar : PubMed/NCBI
22	Chong JH, Zheng GG, Zhu XF, et al: Abnormal expression of P2X family receptors in Chinese pediatric acute leukemias. Biochem Biophys Res Commun. 391:498–504. 2010. View Article : Google Scholar
23	Raffaghello L, Chiozzi P, Falzoni S, Di Virgilio F and Pistoia V: The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res. 66:907–914. 2006. View Article : Google Scholar : PubMed/NCBI
24	Solini A, Cuccato S, Ferrari D, et al: Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? Endocrinology. 149:389–396. 2008. View Article : Google Scholar
25	Slater M, Danieletto S, Pooley M, Cheng TL, Gidley-Baird A and Barden JA: Differentiation between cancerous and normal hyperplastic lobules in breast lesions. Breast Cancer Res Treat. 83:1–10. 2004. View Article : Google Scholar : PubMed/NCBI
26	Souza CO, Santoro GF, Figliuolo VR, et al: Extracellular ATP induces cell death in human intestinal epithelial cells. Biochim Biophys Acta. 1820:1867–1878. 2012. View Article : Google Scholar : PubMed/NCBI
27	Bian S, Sun X, Bai A, et al: P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death. PLoS One. 8:e601842013. View Article : Google Scholar : PubMed/NCBI